No Data
No Data
LifeMD to Participate in Three Investor Conferences During November
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
LifeMD Analyst Ratings
Strong Revenue Growth and Strategic Initiatives Position LifeMD for Continued Expansion Despite Challenges
LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript Summary
Craig-Hallum Maintains LifeMD(LFMD.US) With Buy Rating, Announces Target Price $16
No Data
No Data